0001209191-21-028984.txt : 20210429
0001209191-21-028984.hdr.sgml : 20210429
20210429160330
ACCESSION NUMBER: 0001209191-21-028984
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210427
FILED AS OF DATE: 20210429
DATE AS OF CHANGE: 20210429
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sachdev Amit
CENTRAL INDEX KEY: 0001406338
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 21870381
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-27
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001406338
Sachdev Amit
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Chief Patient Officer
Common Stock
2021-04-27
4
M
0
3884
86.52
A
44017
D
Common Stock
2021-04-27
4
S
0
2346
215.58
D
41671
D
Common Stock
2021-04-27
4
S
0
1338
216.67
D
40333
D
Common Stock
2021-04-27
4
S
0
200
217.69
D
40133
D
Common Stock
882
I
401(k)
Common Stock
7368
I
Held in Trust
Stock Option (Right to Buy)
86.52
2021-04-27
4
M
0
3884
0.00
D
2027-02-02
Common Stock
3884
0
D
Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $215.58 (range $215.09 to $216.07).
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $216.67 (range $216.19 to $217.18).
Open market sales reported on this line occurred at a weighted average price of $217.69 (range $217.60 to $217.78).
Fully vested.
/s/ Sabrina Yohai, Attorney-in-Fact
2021-04-29